top of page

What are the future ramifications to Pharma Marketers.

F.D.A. Deal Allows Amarin to Promote Drug for Off-Label Use

Read here:

Considering the FDA denotes this is a special case it still opens pandora's box of off label marketing of ethical pharmaceuticals as long as they are within truthful statements of the appicable clinical study. It will be interesting to see the developments from this action.

Featured Posts
Check back soon
Once posts are published, you’ll see them here.
Recent Posts
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square
bottom of page